More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
9h
GlobalData on MSNZealand Pharma steadfastly upholds amylin-based obesity drug strategyZealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results